A practical checklist for evaluating decentralized trial technology vendors, built from an RF engineer’s view of where data quality actually breaks.
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
Enhancing The Accessibility And Affordability Of Healthcare
The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
-
Taking Advantage Of EMA CTR For eCOA Studies In EU
Discover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).
-
Helping To Power The WHO Solidarity Trial Against COVID-19
To overcome the unprecedented challenges of large-scale global clinical trials, adopting data capture solutions is essential for ensuring the success of critical research initiatives.
-
To Counter Bias, Counterbalance
It’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.
-
Reflections From ISOQOL Conference 2024
Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.
-
Beyond The Pandemic: Why eCOAs Are Here To Stay
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
Clinical Trial Logistics: Meeting Unique Participant Needs
Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.
-
AI In Clinical Trials: Practical Use Cases For Data Management
AI is improving daily data management with automation, faster issue detection, and smarter reviews. This piece outlines practical use cases and what teams need to enable real, sustainable adoption.
-
Leading eSource Software Company Receives Part 11/Annex 11 Verification
Uncover how an independent confirmation of compliance opened up new opportunities and is instilling confidence in customers who are integrating the eSource system into their software validation strategy.
RECENT NEWSLETTERS
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech